SCHEMBL7467279

SCHEMBL7467279

Nc1c(F)c(Cl)cc2nc(Cl)c(Cl)nc12

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.32
ACHE P22303 1/20 0.31
KHK P50053 1/20 0.30
CASP6 P55212 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6683153 0.80 TDP1 (0.34) TDP1ACHECASP6
SCHEMBL7465264 0.78 HRH4 (0.36)
SCHEMBL7469027 0.77 KHK (0.33) TDP1KHK
SCHEMBL7478802 0.77 GRIN2D (0.35) TDP1ACHECASP6
SCHEMBL7465708 0.73 GAA (0.34)
SCHEMBL7471483 0.70 ALDH1A1 (0.39) TDP1CASP6
SCHEMBL28558287 0.69 TDP1 (0.36) TDP1
SCHEMBL7472208 0.69 TDP1 (0.32) TDP1ACHE
SCHEMBL7476392 0.69 ALDH1A1 (0.36) TDP1ACHE
SCHEMBL7470290 0.69 SMN1; SMN2 (0.37) TDP1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0783495-B1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER LTD (GB) 2002-02-27 EP disclosed
US-5852016-A Quinoxaline derivatives useful in therapy PFIZER INC. (US) 1998-12-22 US disclosed
EP-0783495-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY Pfizer Limited (GB) 1997-07-16 EP disclosed
WO-1996009295-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER LIMITED (GB) 1996-03-28 WO disclosed